Our Technology

Extracellular Vesicle

A natural drug delivery nanocarrier

Extracellular vesicles (EVs) are nano-sized vesicles secreted by most types of cells and have an important role in cell-to-cell communication. They contain a natural cargo including various protein and nucleic acid molecules originated from their donor cells.

Recently, EVs have emerged as a biocompatible Drug Delivery System (DDS) compared to synthetic nanoparticles. Therefore, EVs are considered to be a new class of natural DDS nanocarrier with great potential for clinical application.

Extracellular vesicles released from a cell
Extracellular vesicle structure
SWEET™ Platform technology

Shock Wave Extracellular
Vesicle Engineering Technology

SWEET™ is the abbreviation for 'Shock Wave Extracellular Vesicle Engineering Technology'. SWEET™ is an innovative platform technology for the production of EV-based drug delivery systems using Extracorporeal Shock Wave (ESW). Our SWEET™ is a versatile platform technology that can apply various kinds of EVs and target molecules (siRNA, miRNA, or protein).

We believe that our innovative SWEET™ platform allows us to generate target molecule-encapsulated EVs with high loading efficiency that can be applied to various diseases with significant unmet medical needs. Therefore, the SWEET™ platform has high potential to be applied for infinite pipelines depending on the source of EVs and cargo materials.

Exollence Co., Ltd. provides the EV-based drug delivery platform technology. If you have target molecules (siRNA, miRNA, or protein) of interest that you want to load into EVs, please contact us and discuss your project.

Patent

    Newschevron_right

    Latest news and press coverage of Exollence.

    Noticechevron_right

    Shareholder meeting notices and announcements.

    Pipelineschevron_right

    EB-TM1, EB-PO1 and EB-Vac1 development status.

    Contactchevron_right

    Discuss EV supply and API loading services.